The ETF receives a Hold rating (Zacks Rank 3) with mixed performance indicators. While it offers low costs (0.37% expense ratio), transparency, and reasonable diversification with 51 holdings, it has underperformed with a 12.46% year-to-date decline. The fund is described as 'reasonable' but not exceptional, suggesting neither strong recommendation nor warning.
NYSE Arca · IHI
iShares U.S. Medical Devices ETF news
$51.96+0.70%
Close Sep 28, 2026 · split-adjustedArticles · 30 days1English, de-duplicated
Positive00% of coverage
Neutral1100%
Negative00% of coverage
About iShares U.S. Medical Devices ETF
Zacks Investment ResearchSep 2, 6:20 AM ETNeutral
Also mentions IHI
Articles that tag IHI but are mainly about other companies.
None recently.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology